A carregar...
Olaparib and Enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling
Hepatocellular carcinoma (HCC) is one of most common cancers worldwide, however, the treatment for advanced HCC remains unsatisfactory. We focused on the function of the androgen receptor (AR) in HCC and tried to find new treatment strategy based on antiandrogen Enzalutamide (Enz). Here we found tha...
Na minha lista:
| Publicado no: | FASEB J |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243671/ https://ncbi.nlm.nih.gov/pubmed/32134529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201903045RR |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|